Phase 3Status unknownAge-related condition
Metformin, a diabetes medicine for treatment of knee osteoarthritis in overweight and obese adults
Metformin for knee osteoarthritis in patients with overweight or obesity A randomized control clinical trial - METKOA
- Sponsor
- Government hospital Gandhi nagar
- Enrollment
- 102 planned
- Conditions
- Health Condition 1: M179- Osteoarthritis of knee, unspecified
- Interventions
- metformin tablets
- Registry
- CTRI-2026-08-115942
Full record on the Clinical Trials Registry – IndiaSource: WHO ICTRP, processed September 14, 2026
Primary outcomes
- change in knee pain intensity measured by 0-100 mm visual analogue scale from baseline to 24 weeksTimepoint: baseline and 24 weeks
History
Last registry update
Started
Registered